EchoNous Vein Receives FDA Approval, A New Innovation Designed for Nurses to Improve First-Time Peripheral IV Catheter Insertion

EchoNous,
an innovator focused on delivering intelligent medical tools, has
received U.S. Food and Drug Administration (FDA) 510(k) clearance for
the EchoNous Vein™, an ultrasound-based tool designed specifically for
nurses to improve peripheral IV (PIV) catheter placements. Developed for
usage across a wide range of patients including both adults and
children, EchoNous Vein provides immediate, clear images at depths from
1 to 5 centimeters for quickly visualizing superficial and deeper veins
with just two-button controls. EchoNous Vein will integrate with the
company’s existing intelligent medical tool, Uscan, to form the EchoNous
platform.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180711005836/en/

EchoNous has received U.S. FDA 510(k) clearance for the EchoNous Vein™, an ultrasound-based tool designed specifically for nurses to improve peripheral IV (PIV) catheter placements. (Photo: Business Wire)

One of the most commonly performed minimally-invasive procedures,
peripheral IVs can be challenging due to chronic illness, chemotherapy,
obesity and drug abuse; first-attempt IV catheter insertion fails in up
to 26% of adults and 54% of children1.

“Time is critical, especially when patients need an infusion or
antibiotic treatment, and finding the right vein can be challenging. We
designed the EchoNous Vein to provide nurses with rapid, clear images of
veins to directly improve patient care, satisfaction and HCAHPS scores,”
said Kevin Goodwin, CEO of EchoNous. “We wanted to create an easy-to-use
tool that would help to reduce failed sticks, as with each failure comes
a much higher risk of vessel trauma or infections which can lead to
longer stays in hospital and higher medical costs.”

Early feedback from healthcare providers has shown the EchoNous Vein’s
unique frequency profile and optimized gain and depth presets have the
potential to provide significant advancements in evaluating veins of
pediatric patients – a traditionally challenging patient population for
IV insertion.

“EchoNous Vein’s simple on-screen controls allows clinicians using
ultrasound to clearly identify veins in the center of the display,
helping to not just locate veins, but to evaluate their health and
quality prior to peripheral IV placement,” said Nancy Moureau, RN, PhD,
CEO of PICC Excellence, Inc. “As clinicians we know that IV insertion
selecting a healthy vein for catheter placement can help to reduce the
chance of post insertional complications. To have a tool specifically
designed to easily select veins and guide catheter placement is
extremely valuable as we’re always looking to improve the patient
experience.”

In addition to launching the new vascular access tool, the company also
announces its plan to converge its Signostics brand and AI-driven Uscan
bladder scanner product under the single EchoNous brand.

“The Signostics brand served as our entry point into the U.S. healthcare
market, centered on the success of our AI-driven bladder volume
measurement tool which combines machine learning with highly
miniaturized ultrasound,” said Goodwin.

Healthcare systems interested in an in-person demonstration of EchoNous
Vein should contact sales@echonous.com,
and visit www.echonous.com
for further product specifications, images and videos.

Citation:

1Helm, Robert E., et al. Accepted but Unacceptable:
Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015
May-Jun;38(3):189-203.

About EchoNous

Headquartered in Seattle, Washington, EchoNous, a KKR portfolio company
and parent company of Signostics, is developing an expanding family of
intelligent medical tools to help healthcare professionals solve common
everyday problems in healthcare. Beginning with the EchoNous Vein
vascular access tool and the Uscan intelligent bladder scanner, EchoNous
is applying a layer of artificial intelligence to extreme miniaturized
ultrasound to provide nurses, doctors and clinicians with high-quality,
easy-to-use tools simplifying the task at hand. CEO and industry
innovator Kevin Goodwin and EVP, COO & CIO Niko Pagoulatos, PhD, a
prolific engineering leader, together direct the company based on
decades of successful experience and new category creation in the
ultrasound industry. For more information, visit www.echonous.com.

Signostics and Uscan are Trademarks of Signostics Limited.

Caution: Federal (USA) law restricts this device to sale by or on the
order of a physician.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180711005836/en/

Leave a Comment